EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms

Anna Dar, Adam C Seegmiller

Am J Clin Pathol · 2026

DOI: 10.1093/ajcp/aqaf152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Am J Clin Pathol, 2026. Verfasst von Anna Dar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States. Hauptthemen laut MEDLINE: Flow Cytometry, Algorithms, Hematologic Neoplasms. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Although peripheral blood flow cytometry (PBFC) can aid in the diagnosis of hematolymphoid malignancies, it is often ordered in clinical situations for which it is not useful. We hypothesized that patient clinical data could be used to design an algorithm to guide better test utilization and performance.

Methods

Patient records for 250 consecutive PBFC orders were reviewed to determine test indication, patient demographics and history, blood count, and leukocyte differential. These variables were analyzed to determine whether they could predict the detection of hematolymphoid malignancy. Using these data, a test ordering algorithm was designed to maximize positive and minimize negative results, which was then validated on an additional set of 250 consecutive cases.

Results

Peripheral blood flow cytometry was infrequently positive for most indications. The presence of circulating blasts, history of hematolymphoid malignancy, and lymphocytosis or pancytopenia in patients 50 years of age and older are most predictive of positive results. Application of an algorithm incorporating these criteria would substantially reduce PBFC utilization while increasing the fraction of positive cases. Similar results were seen when the algorithm was applied to an independent validation set.

Conclusions

An evidence-based algorithm for ordering PBFC based on 5 clinical factors can substantially reduce utilization and increase positive results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryAlgorithmsHematologic NeoplasmsHumansMiddle AgedFemaleAdultAgedMaleAdolescentAged, 80 and overChildYoung AdultEvidence-Based MedicineChild, Preschool

Stichwörter der Autor:innen

flow cytometryhematologic malignancytest utilization

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.

Zitieren

APA

Dar, A., & Seegmiller, A. C. (2026). An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms. Am J Clin Pathol. https://doi.org/10.1093/ajcp/aqaf152

Vancouver

Dar A, Seegmiller AC. An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms. Am J Clin Pathol. 2026. doi:10.1093/ajcp/aqaf152

BibTeX
@article{Dar2026,
  author = {Dar, Anna and Seegmiller, Adam C},
  title = {An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms},
  journal = {Am J Clin Pathol},
  year = {2026},
  doi = {10.1093/ajcp/aqaf152}
}
Kostenlos starten →